Expression of an ornithine decarboxylase dominant-negative mutant reverses eukaryotic initiation factor 4E-induced cell transformation

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5136-5140

  Shantz, Lisa M ^a   Coleman, Catherine S ^a   Pegg, Anthony E ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR; ORNITHINE DECARBOXYLASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER GRAFT; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; TUMOR VOLUME;

3T3 CELLS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; MICE; MICE, NUDE; MUTATION; ORNITHINE DECARBOXYLASE; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 0029830792     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Pause, A., Belsham, G J , Gingras, A-C., Donzé, O., Lin T-A , Lawrence, J. C , and Sonenberg, N. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature (Lond.), 371: 762-767, 1994.
2. Lin, T-A , Kong, X , Haystead, T. A., Pause, A , Belsham, G . Sonenberg, N., and Lawrence, J. C. PHAS-I as a link between mitogen-activated protein kinase and translation initiation Science (Washington DC), 266: 653-656, 1994.
3. Lazaris-Karatzas, A , Montine, K. S., and Sonenberg, N Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap Nature (Lond.), 345: 544-547, 1990.
4. Lazaris-Karatzas, A., Smith, M R , Fredrickson, R. M , Jaramillo, M. L., Liu, Y., Kung, H., and Sonenberg, N. Ras mediates translation initiation factor 4E-induced malignant transformation Genes Dev., 6: 1631-1642, 1992
5. Koromilas, A E , Lazaris-Karatzas, A , and Sonenberg, N mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO J., 11: 4153-4158, 1992
6. Shantz, L M., and Pegg, A E. Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res . 54: 2313-2316, 1994
7. Shantz, L. M , Hu, R-H , and Pegg, A. E. Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor eIF-4E Cancer Res., 56: 3265-3269, 1996
8. Rousseau, D , Kaspar, R , Rosenwald, I , Gehrke, L . and Sonenberg, N. Translation initiation of ornithine decarboxylase and nucleoplasmic transport of cyclin D1 are increased in cells overexpressing eukaryotic initiation factor eIF-4E. Proc. Natl. Acad. Sci USA, 93: 1065-1070, 1996.
9. Manzella, J. M., Rychlik, W., Rhoads, R. E., Hershey, J. W B , and Blackshear, P J. Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eukaryotic initiation factors eIF-4B and eIF-4E. J. Biol. Chem , 266: 2383-2389, 1991
10. Grens, A., and Scheffler, I. E. The 5′- and 3′-untranslated regions of ornithine decarboxylase mRNA affect the translational efficiency. J. Biol. Chem., 265: 11810-11816, 1990.
11. Ito, K., Kashiwagi, K., Watanabe, S., Kameji, T., Hayashi, S., and Igarashi, K. Influence of the 5′-untranslated region of ornithine decarboxylase mRNA and spermidine on ornithine decarboxylase synthesis J. Biol. Chem., 265: 13036-13041, 1990
12. Pegg, A E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res , 48: 759-774, 1988.
13. Clifford, A., Morgan, D., Yuspa, S H., Peralta Soler, A., and Gilmour, S Role of ornithine decarboxylase in epidermal tumorigenesis. Cancer Res., 55: 1680-1686, 1995
14. McCann, P. P., and Pegg, A. E. Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther., 54: 195-215, 1992.
15. Auvinen, M., Paasinen, A., Andersson, L. A , and Holttä, E. Ornithine decarboxylase activity is critical for cell transformation Nature (Lond.), 360: 355-358, 1992.
16. Moshier, J. S., Dosescu, J., Skunca, M., and Luk, G. D. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res , 53: 2618-2622, 1993.
17. Coleman, C. S , Stanley, B. A., and Pegg, A. E. Effect of mutations at active site residues on the activity of ornithine decarboxylase and its inhibition by active site-directed irreversible inhibitors. J. Biol. Chem., 268: 24572-24579, 1994.
18. Coleman, C S., Stanley, B. A., Viswanath, R., and Pegg, A. E. Rapid exchange of subunits of mammalian ornithme decarboxylase J. Biol. Chem., 269: 3155-3158, 1994
19. Lu, L., Stanley, B A , and Pegg, A. E. Identification of residues in ornithine decarboxylase essential for enzymatic activity and for rapid protein turnover. Biochem J., 277: 671-675, 1991
20. Tomaydo, M M , and Reynolds, C. P. Determination of subcutaneous tumor size in athymic (nude) mice Cancer Chemother Pharmacol., 24: 148-154, 1989.
21. Hibshoosh, H , Johnson, M., and Weinstein, I B. Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation. Oncogene, 6: 739-743, 1991
22. Höltta, E , Sistonen, L , and Alitalo, K. The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol. Chem , 263: 4500-4507, 1988.
23. Sistonen, L., Hölttä, E., Lehvaslaiho, H., Lehtola, L , and Alitalo, K. Activation of the neu tyrosine kinase induces fos/jun transcription factor complex, the glucose transporter, and ornithine decarboxylase. J. Cell. Biol., 109: 1911-1919, 1989
24. v-src delineation of molecular events relevant for the transformed phenotype. J. Cell Biol., 122: 903-914, 1993.
25. va1 12 oncogene in transformed cell clones. Exp. Cell Res., 168: 518-530, 1987.
26. CAS. Mol. Cell. Biol., 15: 6513-6525, 1995.